Illumina Accelerator

[Not Yet Scheduled]
Illumina Accelerator is a company creation engine building and investing in early-stage startups with extensive mentorship, financial support, and access to genomics systems and lab space in the SF Bay Area and Cambridge (UK). Every 6 months, Illumina Accelerator invests in 3-5 startups advancing breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, software/hardware, and direct-to-consumer. Collectively, our 61 graduates have raised nearly $1B in the last few years. Illumina Accelerator has recently expanded with an incubator in Shanghai in partnership with Sequoia VC, and a genomics hub in Melbourne in partnership with local government and academic entities. The goal of the talk is to showcase the Illumina Accelerator story, how our startups are leveraging genomics to change biotech and healthcare, and how to optimally deploy alternative entrepreneurship models in different ecosystems (e.g., incubator, accelerator, research hub).
Ticker:
ILMN
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Sequencing platforms
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided